Close Menu

NEW YORK (GenomeWeb) — Sphere Fluidics announced today that it has closed a $2 million investment round.

Investors in the round included Greenwood Way Capital, Oxford Technology and Innovations, EIS Fund, and 24Haymarket.  

Cambridge, England-based Sphere said it will use the funding to expand its operations and support sales of its Cyto-Mine single-cell analysis system.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Sponsored by

This webinar will overview the potential for liquid biopsy approaches to monitor therapy resistance in lung cancer.